Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Warner-Lambert

This article was originally published in The Tan Sheet

Executive Summary

Cool Mint Listerine PocketPaks breath strips launch delayed, firm acknowledges. The new launch date is Jan. 16. The product, a novel delivery form of Listerine's essential oils, was slated for an August debut (1"The Tan Sheet" Feb. 28, p. 3). W-L cited Better-than-expected demand from retailers as the reason for the postponement. W-L also is developing a relaunch of its Listerine toothpaste

You may also be interested in...



PediaCare For Older Children, Sudafed Sinus Nighttime Debuting Late Summer

Pharmacia is launching two PediaCare line extensions in an attempt to "up-age" the venerable children's cough/cold line, the company said at the National Association of Chain Drug Stores Marketplace 2001 in Las Vegas June 28-July 2.

PediaCare For Older Children, Sudafed Sinus Nighttime Debuting Late Summer

Pharmacia is launching two PediaCare line extensions in an attempt to "up-age" the venerable children's cough/cold line, the company said at the National Association of Chain Drug Stores Marketplace 2001 in Las Vegas June 28-July 2.

PediaCare For Older Children, Sudafed Sinus Nighttime Debuting Late Summer

Pharmacia is launching two PediaCare line extensions in an attempt to "up-age" the venerable children's cough/cold line, the company said at the National Association of Chain Drug Stores Marketplace 2001 in Las Vegas June 28-July 2.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091393

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel